NEW YORK (GenomeWeb News) – Pressure BioSciences said in a filing with the US Securities and Exchange Commission today that Cole-Parmer has signed an agreement to distribute the firm's PBI Shredder SG3 System on a non-exclusive basis.

The PBI Shredder is used for extraction of DNA, RNA, protein, mitochondria, and small molecules and creates a closed system in which to prepare samples for further analysis.

Terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.